Prostaglandin D(2) metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP(2) receptor

BACKGROUND: Prostaglandin D(2) (PGD(2)) signaling via prostaglandin D(2) receptor 2 (DP(2)) contributes to atopic and non-atopic asthma. Inhibiting DP(2) has shown therapeutic benefit in certain subsets of asthma patients, improving eosinophilic airway inflammation. PGD(2) metabolites prolong the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Carstensen, Saskia, Gress, Christina, Erpenbeck, Veit J., Kazani, Shamsah D., Hohlfeld, Jens M., Sandham, David A., Müller, Meike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499518/
https://www.ncbi.nlm.nih.gov/pubmed/34620168
http://dx.doi.org/10.1186/s12931-021-01852-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499518/
https://www.ncbi.nlm.nih.gov/pubmed/34620168
http://dx.doi.org/10.1186/s12931-021-01852-3

Ejemplares similares